Evaluation of the Vitotox and RadarScreen assays for the rapid assessment of genotoxicity in the early research phase of drug development.

The Vitotox and RadarScreen assays were evaluated as early screens for mutagenicity and clastogenicity, respectively. The Vitotox assay is a bacterial reporter assay in Salmonella typhimurium based on the SOS-response, and it contains a luciferase gene under control of the recN promoter. The RadarScreen assay is a RAD54 promoter-linked beta-galactosidase reporter assay in yeast. The expression of this beta-galactosidase can easily be quantified by use of the substrate d-luciferin-o-beta-galactopyranoside, which is converted into galactose and luciferin that can be measured luminometrically. Recently, an ECVAM workgroup defined a list of 20 genotoxic and 42 non-genotoxic compounds [D. Kirkland, P. Kasper, L. Muller, R. Corvi, G. Speit, Recommended lists of genotoxic and non-genotoxic chemicals for assessment of the performance of new or improved genotoxicity tests: a follow-up to an ECVAM workshop, Mutat. Res. 653 (2008) 99-108.] that can be used for the validation and/or optimization of in vitro genotoxicity assays. In the present study, this compound set was used for the validation of the assays. Moreover, an additional set of 192 compounds was used to broaden this validation study. The compounds of this additional set can be classified as non-genotoxins and genotoxins and consists of both in-house and reference compounds. In case of the ECVAM compound list, the results from the Vitotox and RadarScreen assays were compared to the genotoxic/non-genotoxic classification of the compounds in this list. In case of the additionally tested compounds, the results of the Vitotox and RadarScreen assays were compared, respectively, with bacterial mutagenicity (Ames) results or in vitro clastogenicity data obtained in-house or from the literature. The validation with respect to the ECVAM compound list resulted in a sensitivity for both the Vitotox and RadarScreen assay of 70% (14/20). If both assays were combined the sensitivity increased to 85% (17/20). Both tests also gave a low number of false positive results. The specificity of the Vitotox and RadarScreen assays was 93% (39/42) and 83% (35/42), respectively. This resulted in a predictivity of the Vitotox and RadarScreen assay of 85% (53/62) and 79% (49/62), respectively. In case both tests were combined the specificity and the predictivity of the Vitotox and RadarScreen assay turned out to be 81% (34/42) and 82% (51/62), respectively. The results from the additional list of 192 compounds confirmed the results found with the ECVAM compound list. The results from the Vitotox assay showed a high correlation with Ames test of 91% (132/145). Subsequently, the RadarScreen assay had a correlation with in vitro clastogenicity of 76% (93/123). The specificity of the Vitotox assay was 94% (90/96) for Ames test results and that of the RadarScreen assay was 74% (34/46) for clastogenicity. Moreover, the sensitivities of the Vitotox and RadarScreen assays were 86% (42/49) and 77% (59/77), respectively. Implementation of the Vitotox and RadarScreen assays in the early research phase of drug development can lead to fast de-selection for genotoxicity. It is expected that this application will reduce the number of compounds that have a positive score in the regulatory Ames and clastogenicity tests. Moreover, problems with a complete compound class can be foreseen at an early time point in the research phase, which gives more time for issue resolution than late detection of these problems with the regulatory tests.

[1]  W. Schoonen,et al.  Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells. , 2007, Toxicology in vitro : an international journal published in association with BIBRA.

[2]  S. Kim,et al.  Mutagenic events induced by 4-hydroxyequilin in supF shuttle vector plasmid propagated in human cells. , 2003, Carcinogenesis.

[3]  L. Verschaeve,et al.  VITOTOX® bacterial genotoxicity and toxicity test for the rapid screening of chemicals , 1999, Environmental and molecular mutagenesis.

[4]  R. Walmsley,et al.  The GreenScreen genotoxicity assay: a screening validation programme. , 2004, Mutagenesis.

[5]  J. Barrett,et al.  17β‐Estradiol, diethylstilbestrol, tamoxifen, toremifene and ICI 164,384 induce morphological transformation and aneuploidy in cultured Syrian hamster embryo cells , 1997 .

[6]  M. Hofnung,et al.  The SOS chromotest: a review. , 1993, Mutation research.

[7]  L. Oberley,et al.  Mitochondrial Production of Reactive Oxygen Species Mediate Dicumarol-induced Cytotoxicity in Cancer Cells* , 2006, Journal of Biological Chemistry.

[8]  A. Martelli,et al.  Species, sex and inter-individual differences in DNA repair induced by nine sex steroids in primary cultures of rat and human hepatocytes. , 2003, Mutation research.

[9]  T. Sofuni,et al.  Detection of in vitro clastogens and spindle poisons by the mouse lymphoma assay using the microwell method: interim report of an international collaborative study. , 1996, Mutagenesis.

[10]  H. Rosenkranz,et al.  SOS induction in Escherichia coli and Salmonella mutagenicity: a comparison using 330 compounds. , 1994, Mutagenesis.

[11]  The structure-function relationships of nitrofluorenes and nitrofluorenones in the Salmonella mutagenicity and CHO sister-chromatid exchange assays. , 1988, Mutation research.

[12]  A. Martelli,et al.  Evaluation of flutamide genotoxicity in rats and in primary human hepatocytes. , 2000, Pharmacology & toxicology.

[13]  M. Hofnung,et al.  The SOS Chromotest, a colorimetric bacterial assay for genotoxins: procedures. , 1985, Mutation research.

[14]  A. Martelli,et al.  DNA fragmentation, DNA repair and apoptosis induced in primary rat hepatocytes by dienogest, dydrogesterone and 1,4,6-androstatriene-17beta-ol-3-one acetate. , 2004, Mutation research.

[15]  Ronald D Snyder,et al.  DNA intercalative potential of marketed drugs testing positive in in vitro cytogenetics assays. , 2006, Mutation research.

[16]  J. Shaddock,et al.  Genotoxicity of tacrine in primary hepatocytes isolated from B6C3F1 mice and aged ad libitum and calorie restricted Fischer 344 rats. , 1995, Mutation research.

[17]  G. Horbach,et al.  Genotoxicity of hormonal steroids. , 2004, Toxicology letters.

[18]  Richard M Walmsley,et al.  Assessment of the genotoxicity of S9-generated metabolites using the GreenScreen HC GADD45a-GFP assay. , 2008, Mutagenesis.

[19]  A. Mukhopadhyay,et al.  Mutagenicity assay in Salmonella and in vivo sister chromatid exchange in bone marrow cells of mice for four pyrazolone derivatives. , 1998, Mutation research.

[20]  R. Snyder,et al.  The influence of N-dialkyl and other cationic substituents on DNA intercalation and genotoxicity. , 2005, Mutation research.

[21]  S. Matsuyama,et al.  Chromosomes in patients receiving methadone and methadyl acetate. , 1978, Archives of general psychiatry.

[22]  J. Dayan,et al.  Study of the mutagenic activity of 6 hepatotoxic pharmaceutical drugs in the Salmonella typhimurium microsome test, and the HGPRT and Na+/K+ ATPase system in cultured mammalian cells. , 1985, Mutation research.

[23]  O. Mazina,et al.  Interactions of Human Rad54 Protein with Branched DNA Molecules* , 2007, Journal of Biological Chemistry.

[24]  B. A. al-Hawary,et al.  Cytogenetic effects of dacarbazine on mouse bone marrow cells in vivo. , 1989, Mutation research.

[25]  Richard M Walmsley,et al.  High-specificity and high-sensitivity genotoxicity assessment in a human cell line: validation of the GreenScreen HC GADD45a-GFP genotoxicity assay. , 2006, Mutation research.

[26]  J. Murray,et al.  Mutagenic activity of antileprosy drugs and their derivatives. , 1983, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

[27]  H S Rosenkranz,et al.  Assembly and preliminary analysis of a genotoxicity data base for predicting carcinogens. , 1985, Mutation research.

[28]  Y. Takeda,et al.  Formation of nitroso compounds and mutagens from tranquilizers by drug/nitrite interaction. , 1981, Cancer letters.

[29]  W. Schoonen,et al.  High-throughput screening for analysis of in vitro toxicity. , 2009, EXS.

[30]  In vitro short-term test evaluation of catecholestrogens genotoxicity , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[31]  W. Schoonen,et al.  Phase II enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells. , 2007, Toxicology in vitro : an international journal published in association with BIBRA.

[32]  L. Poirier,et al.  S-adenosyl-L-methionine is able to reverse micronucleus formation induced by sodium arsenite and other cytoskeleton disrupting agents in cultured human cells. , 2003, Mutation research.

[33]  J W Green,et al.  A review of the genotoxicity of marketed pharmaceuticals. , 2001, Mutation research.

[34]  G. Klein,et al.  Investigations of the influence of nonsteroidal antirheumatic drugs on the rates of sister-chromatid exchange. , 1986, Mutation research.

[35]  E. Zeiger,et al.  Chromosome aberrations and sister chromatid exchanges in chinese hamster ovary cells: Evaluations of 108 chemicals , 1987, Environmental and molecular mutagenesis.

[36]  Ronald D Snyder,et al.  SFTG international collaborative study on in vitro micronucleus test III. Using CHO cells. , 2006, Mutation research.

[37]  A. Haverić,et al.  Cytogenetic Evaluation of Paracetamol Effects in Human Lymphocytes Culture , 2007, Drug and chemical toxicology.

[38]  R. Saxena,et al.  Genotoxicity evaluation of the tricyclic antidepressants amitriptyline and imipramine using human lymphocyte cultures. , 1988, Environmental and molecular mutagenesis.

[39]  T. Oda,et al.  Structure–effect relationship in the induction of mitotic phase-specific abnormality of centrosome integrity and multipolar spindles by steroidal estrogens and their derivatives in cultured mammalian cells , 2001, The Journal of Steroid Biochemistry and Molecular Biology.

[40]  S. De Flora,et al.  Genotoxic activity of five antidepressant hydrazines in a battery of in vivo and in vitro short-term tests. , 1982, Journal of toxicology and environmental health.

[41]  Raffaella Corvi,et al.  Recommended lists of genotoxic and non-genotoxic chemicals for assessment of the performance of new or improved genotoxicity tests: a follow-up to an ECVAM workshop. , 2008, Mutation research.

[42]  S. Lovett,et al.  Regulation of RAD54- and RAD52-lacZ gene fusions in Saccharomyces cerevisiae in response to DNA damage , 1987, Molecular and cellular biology.

[43]  Nicolas Meeùs,et al.  Van Gompel L. , 1986 .

[44]  G. Speit,et al.  The effect on sister-chromatid exchanges of drugs and dyes by intercalation and photoactivation. , 1979, Mutation research.

[45]  J. Parry,et al.  The detection and assessment of the aneugenic potential of selected oestrogens, progestins and androgens using the in vitro cytokinesis blocked micronucleus assay. , 2008, Mutation research.

[46]  T Sofuni,et al.  A comparative analysis of data on the clastogenicity of 951 chemical substances tested in mammalian cell cultures. , 1988, Mutation research.

[47]  B. Ames,et al.  Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[48]  S. Abilev,et al.  A comparative study of mutagenic and SOS-inducing activity of biphenyls, phenanthrenequinones and fluorenones. , 1990, Mutation research.

[49]  R. Reimann,et al.  Studies for a genotoxic potential of some endogenous and exogenous sex steroids. II. communication: Examination for the induction of cytogenetic damage using the chromosomal aberration assay on human lymphocytes in vitro and the mouse bone marrow micronucleus test in vivo , 1996, Environmental and molecular mutagenesis.

[50]  V. Dhillon,et al.  In vitro and in vivo genotoxicity evaluation of hormonal drugs v. mestranol. , 1994, Mutation research.

[51]  P. van Bladeren,et al.  Modulating effects of beta-naphthoflavone on the induction of SCEs by model compounds with emphasis on benzo[a]pyrene. , 1988, Mutation research.

[52]  R. Walmsley,et al.  Genotoxic carcinogen or not genotoxic carcinogen? That is the question Re: Olaharski et al., "Validation of the GreenScreen GADD45alpha-GFP indicator assay with non-proprietary and proprietary compounds". , 2009, Mutation research.

[53]  A. Amiel,et al.  The correlation between the frequency of sister-chromatid exchange and human reproductive hormones. , 1993, Mutation research.

[54]  R. Walmsley,et al.  An assessment of the utility of the yeast GreenScreen assay in pharmaceutical screening. , 2005, Mutagenesis.

[55]  R. Walmsley,et al.  An analysis of results from 305 compounds tested with the yeast RAD54-GFP genotoxicity assay (GreenScreen GC)-including relative predictivity of regulatory tests and rodent carcinogenesis and performance with autofluorescent and coloured compounds. , 2007, Mutagenesis.

[56]  E. Zeiger,et al.  Genetic toxicity studies of 1,2,3,4-tetrahydro-9-acridinamine (tacrine). , 1997, Mutation research.

[57]  S. K. Greenwood,et al.  Chromosome aberrations in vitro related to cytotoxicity of nonmutagenic chemicals and metabolic poisons , 1998, Environmental and molecular mutagenesis.

[58]  Mohammad Afzal,et al.  Genotoxic potential of ethinylestradiol in cultured mammalian cells. , 2005, Chemico-biological interactions.

[59]  Véronique Thybaud,et al.  SFTG international collaborative study on in vitro micronucleus test II. Using human lymphocytes. , 2006, Mutation research.

[60]  W. von der Hude,et al.  Epoxides: comparison of the induction of SOS repair in Escherichia coli PQ37 and the bacterial mutagenicity in the Ames test. , 1990, Mutation research.

[61]  David Kirkland,et al.  Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens III. Appropriate follow-up testing in vivo. , 2005, Mutation research.

[62]  R. Reimann,et al.  Studies for a genotoxic potential of some endogenous and exogenous sex steroids. I. Communication: Examination for the induction of gene mutations using the ames salmonella/microsome test and the HGPRT test in V79 cells , 1993, Environmental and molecular mutagenesis.

[63]  A. Fujii,et al.  Mutagenicity of analgesics, their derivatives, and anti-inflammatory drugs with S-9 mix of several animal species. , 1992, The Journal of Nihon University School of Dentistry.

[64]  L. Verschaeve,et al.  The VITOTOX test, an SOS bioluminescence Salmonella typhimurium test to measure genotoxicity kinetics. , 1997, Mutation research.

[65]  Lutz Müller,et al.  Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity. , 2005, Mutation research.

[66]  S. Broyde,et al.  Equilenin-derived DNA adducts to cytosine in DNA duplexes: structures and thermodynamics. , 2005, Biochemistry.

[67]  Jerry R. Williams,et al.  Comparison of the Ames assay and the induction of sister chromatid exchanges: Results with ten pharmaceuticals and five selected agents , 1986, Cell Biology and Toxicology.

[68]  E. Gocke.  Review of the genotoxic properties of chlorpromazine and related phenothiazines. , 1996, Mutation research.

[69]  J. Nath,et al.  Inhibition of methotrexate-induced chromosomal damage by folinic acid in V79 cells. , 1998, Mutation research.